2020
DOI: 10.20945/2359-3997000000236
|View full text |Cite
|
Sign up to set email alerts
|

ARMC5 mutations are associated with high levels of proliferating cell nuclear antigen and the presence of the serotonin receptor 5HT4R in PMAH nodules

Abstract: Objective To analyze the morphological and functional characteristics of primary macronodular adrenal hyperplasia (PMAH) nodules carrying or not carrying ARMC5 mutations and the consequences of the presence of mutations in terms of the pattern of macronodule composition and functional state. Subjects and methods The analyses were performed by hematoxylin-eosin staining, immunohistochemistry, microdissection of spongiocyte tissue and RT-qPCR of histological sections from… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Recently, Armadillo repeat containing 5 (ARMC5) mutations have been described in familial cases and in sporadic patients with CS [152,153]. Although ARMC5 mutations reduce the steroid secretory capacity of each cell, the overall cortisol secretion is increased due to massive enlargement of the adrenals [154][155][156]. In 2015, the association between ARMC5 and the presence of meningiomas has been described [157].…”
Section: Question 6: Is a Different Management Required For Bilateral Adrenal Incidentaloma?mentioning
confidence: 99%
“…Recently, Armadillo repeat containing 5 (ARMC5) mutations have been described in familial cases and in sporadic patients with CS [152,153]. Although ARMC5 mutations reduce the steroid secretory capacity of each cell, the overall cortisol secretion is increased due to massive enlargement of the adrenals [154][155][156]. In 2015, the association between ARMC5 and the presence of meningiomas has been described [157].…”
Section: Question 6: Is a Different Management Required For Bilateral Adrenal Incidentaloma?mentioning
confidence: 99%
“…Moreover, the missense mutation in the BTB domain of ARMC5 in more than 25–50% of patients with PBMAH, adrenal cortex tumors, and PA is not able to interact and be degraded by the CUL3/proteasome or to alter the cell cycle ( Zilbermint et al, 2015 ; Berthon and Bertherat, 2020 ; Cavalcante et al, 2020 ), which leads to deregulation of cell cycle progression. In addition, ARMC5 mutations can cause increased PCNA expression, which is also a possible cause of these diseases ( Conceição et al, 2020 ).…”
Section: Functional Interactions Of the Armc Subfamily In Specific Diseasesmentioning
confidence: 99%